nodes	percent_of_prediction	percent_of_DWPC	metapath
Olanzapine—ALB—focal segmental glomerulosclerosis	0.599	1	CbGaD
Olanzapine—CYP2C19—Cyclosporine—focal segmental glomerulosclerosis	0.0534	0.258	CbGbCtD
Olanzapine—CYP2C9—Cyclosporine—focal segmental glomerulosclerosis	0.0444	0.214	CbGbCtD
Olanzapine—ABCB1—Cyclosporine—focal segmental glomerulosclerosis	0.0431	0.208	CbGbCtD
Olanzapine—CYP2D6—Cyclosporine—focal segmental glomerulosclerosis	0.0406	0.196	CbGbCtD
Olanzapine—CYP3A4—Cyclosporine—focal segmental glomerulosclerosis	0.0258	0.125	CbGbCtD
Olanzapine—HTR2A—arteriole—focal segmental glomerulosclerosis	0.00461	0.257	CbGeAlD
Olanzapine—HTR7—endothelium—focal segmental glomerulosclerosis	0.00152	0.0845	CbGeAlD
Olanzapine—H1F0—nephron tubule—focal segmental glomerulosclerosis	0.00112	0.0627	CbGeAlD
Olanzapine—ADRA1B—kidney—focal segmental glomerulosclerosis	0.00105	0.0584	CbGeAlD
Olanzapine—H1F0—kidney—focal segmental glomerulosclerosis	0.000988	0.0551	CbGeAlD
Olanzapine—H1F0—cortex of kidney—focal segmental glomerulosclerosis	0.000963	0.0537	CbGeAlD
Olanzapine—HTR2A—endothelium—focal segmental glomerulosclerosis	0.000945	0.0527	CbGeAlD
Olanzapine—HTR1D—kidney—focal segmental glomerulosclerosis	0.000766	0.0427	CbGeAlD
Olanzapine—HTR2B—cortex of kidney—focal segmental glomerulosclerosis	0.000694	0.0387	CbGeAlD
Olanzapine—CHRM3—kidney—focal segmental glomerulosclerosis	0.000641	0.0357	CbGeAlD
Olanzapine—ADRA2C—nephron tubule—focal segmental glomerulosclerosis	0.000638	0.0356	CbGeAlD
Olanzapine—HTR7—kidney—focal segmental glomerulosclerosis	0.00061	0.034	CbGeAlD
Olanzapine—ADRA2C—kidney—focal segmental glomerulosclerosis	0.000561	0.0313	CbGeAlD
Olanzapine—ADRA2C—cortex of kidney—focal segmental glomerulosclerosis	0.000546	0.0305	CbGeAlD
Olanzapine—ADRA2A—cortex of kidney—focal segmental glomerulosclerosis	0.000436	0.0243	CbGeAlD
Olanzapine—HTR2A—kidney—focal segmental glomerulosclerosis	0.00038	0.0212	CbGeAlD
Olanzapine—CYP3A4—kidney—focal segmental glomerulosclerosis	0.000352	0.0196	CbGeAlD
Olanzapine—CYP2D6—kidney—focal segmental glomerulosclerosis	0.000346	0.0193	CbGeAlD
Olanzapine—ABCB1—nephron tubule—focal segmental glomerulosclerosis	0.000284	0.0158	CbGeAlD
Olanzapine—ABCB1—kidney—focal segmental glomerulosclerosis	0.000249	0.0139	CbGeAlD
Olanzapine—ABCB1—cortex of kidney—focal segmental glomerulosclerosis	0.000243	0.0135	CbGeAlD
Olanzapine—DRD1—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	3.34e-05	0.00019	CbGpPWpGaD
Olanzapine—ADRA2C—Hemostasis—TGFB1—focal segmental glomerulosclerosis	3.3e-05	0.000188	CbGpPWpGaD
Olanzapine—DRD3—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	3.3e-05	0.000188	CbGpPWpGaD
Olanzapine—ADRA2C—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	3.28e-05	0.000187	CbGpPWpGaD
Olanzapine—HTR2B—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	3.26e-05	0.000186	CbGpPWpGaD
Olanzapine—DRD2—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	3.25e-05	0.000185	CbGpPWpGaD
Olanzapine—CYP2C9—Metabolism of lipids and lipoproteins—AGT—focal segmental glomerulosclerosis	3.25e-05	0.000185	CbGpPWpGaD
Olanzapine—CYP1A2—Metabolism of lipids and lipoproteins—LPL—focal segmental glomerulosclerosis	3.25e-05	0.000185	CbGpPWpGaD
Olanzapine—DRD1—Signaling Pathways—LPL—focal segmental glomerulosclerosis	3.24e-05	0.000185	CbGpPWpGaD
Olanzapine—HRH2—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	3.23e-05	0.000184	CbGpPWpGaD
Olanzapine—ADRA1B—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	3.23e-05	0.000184	CbGpPWpGaD
Olanzapine—ADRA2C—Metabolism—LPL—focal segmental glomerulosclerosis	3.23e-05	0.000184	CbGpPWpGaD
Olanzapine—CHRM5—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	3.22e-05	0.000184	CbGpPWpGaD
Olanzapine—HTR6—Signaling Pathways—AGT—focal segmental glomerulosclerosis	3.22e-05	0.000184	CbGpPWpGaD
Olanzapine—HTR7—Signaling Pathways—AGT—focal segmental glomerulosclerosis	3.22e-05	0.000183	CbGpPWpGaD
Olanzapine—DRD5—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	3.21e-05	0.000183	CbGpPWpGaD
Olanzapine—HTR2A—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	3.2e-05	0.000182	CbGpPWpGaD
Olanzapine—DRD3—Signaling Pathways—LPL—focal segmental glomerulosclerosis	3.2e-05	0.000182	CbGpPWpGaD
Olanzapine—HTR1D—Signaling Pathways—AGT—focal segmental glomerulosclerosis	3.2e-05	0.000182	CbGpPWpGaD
Olanzapine—HRH1—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	3.19e-05	0.000182	CbGpPWpGaD
Olanzapine—HRH4—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	3.19e-05	0.000182	CbGpPWpGaD
Olanzapine—CHRM1—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	3.18e-05	0.000181	CbGpPWpGaD
Olanzapine—CHRM3—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	3.17e-05	0.000181	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	3.17e-05	0.000181	CbGpPWpGaD
Olanzapine—CHRM2—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	3.14e-05	0.000179	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	3.13e-05	0.000179	CbGpPWpGaD
Olanzapine—HTR1B—Signaling Pathways—AGT—focal segmental glomerulosclerosis	3.13e-05	0.000178	CbGpPWpGaD
Olanzapine—DRD4—Signaling Pathways—AGT—focal segmental glomerulosclerosis	3.08e-05	0.000176	CbGpPWpGaD
Olanzapine—DRD1—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	3.07e-05	0.000175	CbGpPWpGaD
Olanzapine—CYP2C19—Metabolism—LIPC—focal segmental glomerulosclerosis	3.04e-05	0.000173	CbGpPWpGaD
Olanzapine—CHRM4—Signaling Pathways—AGT—focal segmental glomerulosclerosis	3.04e-05	0.000173	CbGpPWpGaD
Olanzapine—DRD3—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	3.03e-05	0.000173	CbGpPWpGaD
Olanzapine—ALB—Metabolism—CTGF—focal segmental glomerulosclerosis	2.98e-05	0.00017	CbGpPWpGaD
Olanzapine—HTR6—Signaling Pathways—FN1—focal segmental glomerulosclerosis	2.98e-05	0.00017	CbGpPWpGaD
Olanzapine—ADRA2B—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	2.98e-05	0.00017	CbGpPWpGaD
Olanzapine—DRD2—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	2.98e-05	0.00017	CbGpPWpGaD
Olanzapine—HTR7—Signaling Pathways—FN1—focal segmental glomerulosclerosis	2.97e-05	0.000169	CbGpPWpGaD
Olanzapine—ABCB1—Metabolism—LIPC—focal segmental glomerulosclerosis	2.97e-05	0.000169	CbGpPWpGaD
Olanzapine—HTR1D—Signaling Pathways—FN1—focal segmental glomerulosclerosis	2.95e-05	0.000168	CbGpPWpGaD
Olanzapine—HTR2B—Signaling Pathways—AGT—focal segmental glomerulosclerosis	2.94e-05	0.000168	CbGpPWpGaD
Olanzapine—HTR2A—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	2.93e-05	0.000167	CbGpPWpGaD
Olanzapine—HRH1—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	2.92e-05	0.000167	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	2.91e-05	0.000166	CbGpPWpGaD
Olanzapine—CHRM1—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	2.91e-05	0.000166	CbGpPWpGaD
Olanzapine—CHRM5—Signaling Pathways—AGT—focal segmental glomerulosclerosis	2.91e-05	0.000166	CbGpPWpGaD
Olanzapine—CHRM3—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	2.9e-05	0.000165	CbGpPWpGaD
Olanzapine—HTR1B—Signaling Pathways—FN1—focal segmental glomerulosclerosis	2.89e-05	0.000165	CbGpPWpGaD
Olanzapine—ADRA2B—Signaling Pathways—LPL—focal segmental glomerulosclerosis	2.89e-05	0.000165	CbGpPWpGaD
Olanzapine—CHRM2—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	2.87e-05	0.000164	CbGpPWpGaD
Olanzapine—HTR1A—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	2.87e-05	0.000164	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	2.87e-05	0.000163	CbGpPWpGaD
Olanzapine—HTR2C—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	2.86e-05	0.000163	CbGpPWpGaD
Olanzapine—CHRM3—Metabolism—LPL—focal segmental glomerulosclerosis	2.86e-05	0.000163	CbGpPWpGaD
Olanzapine—DRD4—Signaling Pathways—FN1—focal segmental glomerulosclerosis	2.85e-05	0.000162	CbGpPWpGaD
Olanzapine—CHRM4—Signaling Pathways—FN1—focal segmental glomerulosclerosis	2.81e-05	0.00016	CbGpPWpGaD
Olanzapine—CYP2D6—Metabolism—LIPC—focal segmental glomerulosclerosis	2.8e-05	0.000159	CbGpPWpGaD
Olanzapine—HTR1A—Signaling Pathways—LPL—focal segmental glomerulosclerosis	2.79e-05	0.000159	CbGpPWpGaD
Olanzapine—ADRA2C—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	2.78e-05	0.000158	CbGpPWpGaD
Olanzapine—CYP1A2—Metabolism of lipids and lipoproteins—AGT—focal segmental glomerulosclerosis	2.78e-05	0.000158	CbGpPWpGaD
Olanzapine—HTR1E—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	2.78e-05	0.000158	CbGpPWpGaD
Olanzapine—CYP2C9—Metabolism—LIPC—focal segmental glomerulosclerosis	2.77e-05	0.000158	CbGpPWpGaD
Olanzapine—HTR2C—Signaling Pathways—LPL—focal segmental glomerulosclerosis	2.77e-05	0.000158	CbGpPWpGaD
Olanzapine—DRD1—Signaling Pathways—AGT—focal segmental glomerulosclerosis	2.77e-05	0.000158	CbGpPWpGaD
Olanzapine—ADRA2C—Metabolism—AGT—focal segmental glomerulosclerosis	2.76e-05	0.000157	CbGpPWpGaD
Olanzapine—ALB—Metabolism—GNAQ—focal segmental glomerulosclerosis	2.75e-05	0.000157	CbGpPWpGaD
Olanzapine—CYP2C19—Metabolism of lipids and lipoproteins—ALB—focal segmental glomerulosclerosis	2.74e-05	0.000156	CbGpPWpGaD
Olanzapine—DRD3—Signaling Pathways—AGT—focal segmental glomerulosclerosis	2.74e-05	0.000156	CbGpPWpGaD
Olanzapine—ADRA1B—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	2.74e-05	0.000156	CbGpPWpGaD
Olanzapine—ADRA2B—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	2.73e-05	0.000156	CbGpPWpGaD
Olanzapine—HTR2B—Signaling Pathways—FN1—focal segmental glomerulosclerosis	2.72e-05	0.000155	CbGpPWpGaD
Olanzapine—ADRA2C—Signaling Pathways—LPL—focal segmental glomerulosclerosis	2.7e-05	0.000154	CbGpPWpGaD
Olanzapine—CHRM5—Signaling Pathways—FN1—focal segmental glomerulosclerosis	2.69e-05	0.000153	CbGpPWpGaD
Olanzapine—ADRA2A—Hemostasis—TGFB1—focal segmental glomerulosclerosis	2.68e-05	0.000153	CbGpPWpGaD
Olanzapine—CYP2C19—Metabolism—CTGF—focal segmental glomerulosclerosis	2.68e-05	0.000153	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	2.66e-05	0.000152	CbGpPWpGaD
Olanzapine—ADRA1B—Signaling Pathways—LPL—focal segmental glomerulosclerosis	2.65e-05	0.000151	CbGpPWpGaD
Olanzapine—HTR1A—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	2.64e-05	0.00015	CbGpPWpGaD
Olanzapine—HRH4—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	2.63e-05	0.00015	CbGpPWpGaD
Olanzapine—HTR2C—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	2.63e-05	0.00015	CbGpPWpGaD
Olanzapine—ADRA2A—Metabolism—LPL—focal segmental glomerulosclerosis	2.62e-05	0.000149	CbGpPWpGaD
Olanzapine—ABCB1—Metabolism—CTGF—focal segmental glomerulosclerosis	2.61e-05	0.000149	CbGpPWpGaD
Olanzapine—DRD1—Signaling Pathways—FN1—focal segmental glomerulosclerosis	2.56e-05	0.000146	CbGpPWpGaD
Olanzapine—ADRA2C—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	2.55e-05	0.000146	CbGpPWpGaD
Olanzapine—ABCB1—Transmembrane transport of small molecules—ALB—focal segmental glomerulosclerosis	2.54e-05	0.000145	CbGpPWpGaD
Olanzapine—DRD3—Signaling Pathways—FN1—focal segmental glomerulosclerosis	2.53e-05	0.000144	CbGpPWpGaD
Olanzapine—DRD2—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	2.52e-05	0.000144	CbGpPWpGaD
Olanzapine—ADRA1B—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	2.51e-05	0.000143	CbGpPWpGaD
Olanzapine—CYP2C9—Metabolism of lipids and lipoproteins—ALB—focal segmental glomerulosclerosis	2.5e-05	0.000142	CbGpPWpGaD
Olanzapine—HTR2A—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	2.48e-05	0.000141	CbGpPWpGaD
Olanzapine—HTR6—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	2.48e-05	0.000141	CbGpPWpGaD
Olanzapine—HRH1—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	2.48e-05	0.000141	CbGpPWpGaD
Olanzapine—HTR7—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	2.47e-05	0.000141	CbGpPWpGaD
Olanzapine—HRH2—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	2.47e-05	0.000141	CbGpPWpGaD
Olanzapine—ADRA2B—Signaling Pathways—AGT—focal segmental glomerulosclerosis	2.47e-05	0.000141	CbGpPWpGaD
Olanzapine—CHRM1—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	2.47e-05	0.000141	CbGpPWpGaD
Olanzapine—CYP2C19—Metabolism—GNAQ—focal segmental glomerulosclerosis	2.47e-05	0.000141	CbGpPWpGaD
Olanzapine—CYP2D6—Metabolism—CTGF—focal segmental glomerulosclerosis	2.46e-05	0.00014	CbGpPWpGaD
Olanzapine—CHRM3—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	2.46e-05	0.00014	CbGpPWpGaD
Olanzapine—HTR1D—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	2.46e-05	0.00014	CbGpPWpGaD
Olanzapine—DRD5—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	2.46e-05	0.00014	CbGpPWpGaD
Olanzapine—DRD2—Signaling Pathways—LPL—focal segmental glomerulosclerosis	2.45e-05	0.000139	CbGpPWpGaD
Olanzapine—CHRM3—Metabolism—AGT—focal segmental glomerulosclerosis	2.44e-05	0.000139	CbGpPWpGaD
Olanzapine—CYP2C9—Metabolism—CTGF—focal segmental glomerulosclerosis	2.44e-05	0.000139	CbGpPWpGaD
Olanzapine—CHRM2—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	2.44e-05	0.000139	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	2.43e-05	0.000139	CbGpPWpGaD
Olanzapine—ABCB1—Metabolism—GNAQ—focal segmental glomerulosclerosis	2.41e-05	0.000137	CbGpPWpGaD
Olanzapine—HTR2A—Signaling Pathways—LPL—focal segmental glomerulosclerosis	2.41e-05	0.000137	CbGpPWpGaD
Olanzapine—HTR1B—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	2.41e-05	0.000137	CbGpPWpGaD
Olanzapine—HRH1—Signaling Pathways—LPL—focal segmental glomerulosclerosis	2.4e-05	0.000137	CbGpPWpGaD
Olanzapine—CHRM1—Signaling Pathways—LPL—focal segmental glomerulosclerosis	2.4e-05	0.000137	CbGpPWpGaD
Olanzapine—CHRM3—Signaling Pathways—LPL—focal segmental glomerulosclerosis	2.39e-05	0.000136	CbGpPWpGaD
Olanzapine—HTR1A—Signaling Pathways—AGT—focal segmental glomerulosclerosis	2.38e-05	0.000136	CbGpPWpGaD
Olanzapine—HTR2C—Signaling Pathways—AGT—focal segmental glomerulosclerosis	2.37e-05	0.000135	CbGpPWpGaD
Olanzapine—CYP1A2—Metabolism—LIPC—focal segmental glomerulosclerosis	2.37e-05	0.000135	CbGpPWpGaD
Olanzapine—DRD4—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	2.37e-05	0.000135	CbGpPWpGaD
Olanzapine—CHRM2—Signaling Pathways—LPL—focal segmental glomerulosclerosis	2.36e-05	0.000135	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling Pathways—LPL—focal segmental glomerulosclerosis	2.36e-05	0.000134	CbGpPWpGaD
Olanzapine—CHRM4—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	2.34e-05	0.000133	CbGpPWpGaD
Olanzapine—DRD2—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	2.32e-05	0.000132	CbGpPWpGaD
Olanzapine—ADRA2C—Signaling Pathways—AGT—focal segmental glomerulosclerosis	2.31e-05	0.000132	CbGpPWpGaD
Olanzapine—HTR1E—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	2.29e-05	0.00013	CbGpPWpGaD
Olanzapine—ADRA2B—Signaling Pathways—FN1—focal segmental glomerulosclerosis	2.28e-05	0.00013	CbGpPWpGaD
Olanzapine—HTR2A—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	2.28e-05	0.00013	CbGpPWpGaD
Olanzapine—HRH1—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	2.28e-05	0.00013	CbGpPWpGaD
Olanzapine—ADRA1B—Signaling Pathways—AGT—focal segmental glomerulosclerosis	2.27e-05	0.000129	CbGpPWpGaD
Olanzapine—CYP2D6—Metabolism—GNAQ—focal segmental glomerulosclerosis	2.27e-05	0.000129	CbGpPWpGaD
Olanzapine—CHRM1—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	2.27e-05	0.000129	CbGpPWpGaD
Olanzapine—CHRM3—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	2.26e-05	0.000129	CbGpPWpGaD
Olanzapine—HTR2B—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	2.26e-05	0.000129	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	2.26e-05	0.000129	CbGpPWpGaD
Olanzapine—CYP2C9—Metabolism—GNAQ—focal segmental glomerulosclerosis	2.25e-05	0.000128	CbGpPWpGaD
Olanzapine—ADRA2A—Metabolism—AGT—focal segmental glomerulosclerosis	2.24e-05	0.000128	CbGpPWpGaD
Olanzapine—CHRM2—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	2.24e-05	0.000128	CbGpPWpGaD
Olanzapine—CHRM5—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	2.24e-05	0.000128	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	2.23e-05	0.000127	CbGpPWpGaD
Olanzapine—HTR1A—Signaling Pathways—FN1—focal segmental glomerulosclerosis	2.2e-05	0.000126	CbGpPWpGaD
Olanzapine—HTR2C—Signaling Pathways—FN1—focal segmental glomerulosclerosis	2.19e-05	0.000125	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—LPL—focal segmental glomerulosclerosis	2.19e-05	0.000125	CbGpPWpGaD
Olanzapine—DRD1—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	2.13e-05	0.000122	CbGpPWpGaD
Olanzapine—ADRA2C—Signaling Pathways—FN1—focal segmental glomerulosclerosis	2.13e-05	0.000122	CbGpPWpGaD
Olanzapine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—focal segmental glomerulosclerosis	2.13e-05	0.000122	CbGpPWpGaD
Olanzapine—ALB—Hemostasis—TGFB1—focal segmental glomerulosclerosis	2.12e-05	0.000121	CbGpPWpGaD
Olanzapine—ADRA2C—Metabolism—ALB—focal segmental glomerulosclerosis	2.12e-05	0.000121	CbGpPWpGaD
Olanzapine—DRD3—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	2.1e-05	0.00012	CbGpPWpGaD
Olanzapine—ADRA1B—Signaling Pathways—FN1—focal segmental glomerulosclerosis	2.1e-05	0.00012	CbGpPWpGaD
Olanzapine—DRD2—Signaling Pathways—AGT—focal segmental glomerulosclerosis	2.09e-05	0.000119	CbGpPWpGaD
Olanzapine—CYP1A2—Metabolism—CTGF—focal segmental glomerulosclerosis	2.09e-05	0.000119	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	2.08e-05	0.000118	CbGpPWpGaD
Olanzapine—ALB—Metabolism—LPL—focal segmental glomerulosclerosis	2.07e-05	0.000118	CbGpPWpGaD
Olanzapine—HTR2A—Signaling Pathways—AGT—focal segmental glomerulosclerosis	2.06e-05	0.000117	CbGpPWpGaD
Olanzapine—HRH1—Signaling Pathways—AGT—focal segmental glomerulosclerosis	2.06e-05	0.000117	CbGpPWpGaD
Olanzapine—CHRM1—Signaling Pathways—AGT—focal segmental glomerulosclerosis	2.05e-05	0.000117	CbGpPWpGaD
Olanzapine—CHRM3—Signaling Pathways—AGT—focal segmental glomerulosclerosis	2.04e-05	0.000116	CbGpPWpGaD
Olanzapine—HRH2—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	2.04e-05	0.000116	CbGpPWpGaD
Olanzapine—DRD5—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	2.03e-05	0.000115	CbGpPWpGaD
Olanzapine—CHRM2—Signaling Pathways—AGT—focal segmental glomerulosclerosis	2.02e-05	0.000115	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling Pathways—AGT—focal segmental glomerulosclerosis	2.02e-05	0.000115	CbGpPWpGaD
Olanzapine—DRD2—Signaling Pathways—FN1—focal segmental glomerulosclerosis	1.93e-05	0.00011	CbGpPWpGaD
Olanzapine—CYP1A2—Metabolism—GNAQ—focal segmental glomerulosclerosis	1.92e-05	0.00011	CbGpPWpGaD
Olanzapine—HTR2A—Signaling Pathways—FN1—focal segmental glomerulosclerosis	1.9e-05	0.000108	CbGpPWpGaD
Olanzapine—HRH1—Signaling Pathways—FN1—focal segmental glomerulosclerosis	1.9e-05	0.000108	CbGpPWpGaD
Olanzapine—ADRA2B—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	1.9e-05	0.000108	CbGpPWpGaD
Olanzapine—HTR6—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	1.9e-05	0.000108	CbGpPWpGaD
Olanzapine—HTR7—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	1.9e-05	0.000108	CbGpPWpGaD
Olanzapine—CHRM1—Signaling Pathways—FN1—focal segmental glomerulosclerosis	1.89e-05	0.000108	CbGpPWpGaD
Olanzapine—CHRM3—Signaling Pathways—FN1—focal segmental glomerulosclerosis	1.89e-05	0.000108	CbGpPWpGaD
Olanzapine—HTR1D—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	1.88e-05	0.000107	CbGpPWpGaD
Olanzapine—CHRM3—Metabolism—ALB—focal segmental glomerulosclerosis	1.87e-05	0.000107	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—AGT—focal segmental glomerulosclerosis	1.87e-05	0.000107	CbGpPWpGaD
Olanzapine—CHRM2—Signaling Pathways—FN1—focal segmental glomerulosclerosis	1.87e-05	0.000107	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling Pathways—FN1—focal segmental glomerulosclerosis	1.86e-05	0.000106	CbGpPWpGaD
Olanzapine—CYP2C19—Metabolism—LPL—focal segmental glomerulosclerosis	1.86e-05	0.000106	CbGpPWpGaD
Olanzapine—HTR1B—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	1.84e-05	0.000105	CbGpPWpGaD
Olanzapine—HTR1A—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	1.83e-05	0.000105	CbGpPWpGaD
Olanzapine—CYP3A4—Metabolism—LIPC—focal segmental glomerulosclerosis	1.83e-05	0.000104	CbGpPWpGaD
Olanzapine—HTR2C—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	1.82e-05	0.000104	CbGpPWpGaD
Olanzapine—DRD4—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	1.81e-05	0.000103	CbGpPWpGaD
Olanzapine—ABCB1—Metabolism—LPL—focal segmental glomerulosclerosis	1.81e-05	0.000103	CbGpPWpGaD
Olanzapine—CHRM4—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	1.79e-05	0.000102	CbGpPWpGaD
Olanzapine—ADRA2C—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	1.77e-05	0.000101	CbGpPWpGaD
Olanzapine—ALB—Metabolism—AGT—focal segmental glomerulosclerosis	1.77e-05	0.000101	CbGpPWpGaD
Olanzapine—ADRA1B—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	1.75e-05	9.95e-05	CbGpPWpGaD
Olanzapine—HTR2B—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	1.73e-05	9.87e-05	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—FN1—focal segmental glomerulosclerosis	1.73e-05	9.87e-05	CbGpPWpGaD
Olanzapine—ADRA2A—Metabolism—ALB—focal segmental glomerulosclerosis	1.72e-05	9.8e-05	CbGpPWpGaD
Olanzapine—CHRM5—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	1.71e-05	9.77e-05	CbGpPWpGaD
Olanzapine—CYP2D6—Metabolism—LPL—focal segmental glomerulosclerosis	1.71e-05	9.73e-05	CbGpPWpGaD
Olanzapine—CYP2C9—Metabolism—LPL—focal segmental glomerulosclerosis	1.69e-05	9.65e-05	CbGpPWpGaD
Olanzapine—DRD1—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	1.63e-05	9.31e-05	CbGpPWpGaD
Olanzapine—DRD3—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	1.61e-05	9.18e-05	CbGpPWpGaD
Olanzapine—CYP3A4—Metabolism—CTGF—focal segmental glomerulosclerosis	1.61e-05	9.18e-05	CbGpPWpGaD
Olanzapine—DRD2—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	1.61e-05	9.18e-05	CbGpPWpGaD
Olanzapine—CYP2C19—Metabolism—AGT—focal segmental glomerulosclerosis	1.59e-05	9.05e-05	CbGpPWpGaD
Olanzapine—HTR2A—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	1.58e-05	9.03e-05	CbGpPWpGaD
Olanzapine—HRH1—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	1.58e-05	9.01e-05	CbGpPWpGaD
Olanzapine—CHRM1—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	1.58e-05	8.98e-05	CbGpPWpGaD
Olanzapine—CHRM3—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	1.57e-05	8.95e-05	CbGpPWpGaD
Olanzapine—HTR6—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	1.56e-05	8.91e-05	CbGpPWpGaD
Olanzapine—HTR7—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	1.56e-05	8.9e-05	CbGpPWpGaD
Olanzapine—CHRM2—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	1.56e-05	8.86e-05	CbGpPWpGaD
Olanzapine—HTR1D—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	1.55e-05	8.84e-05	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	1.55e-05	8.84e-05	CbGpPWpGaD
Olanzapine—ABCB1—Metabolism—AGT—focal segmental glomerulosclerosis	1.55e-05	8.83e-05	CbGpPWpGaD
Olanzapine—HTR1B—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	1.52e-05	8.66e-05	CbGpPWpGaD
Olanzapine—DRD4—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	1.5e-05	8.52e-05	CbGpPWpGaD
Olanzapine—CYP3A4—Metabolism—GNAQ—focal segmental glomerulosclerosis	1.48e-05	8.46e-05	CbGpPWpGaD
Olanzapine—CHRM4—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	1.48e-05	8.41e-05	CbGpPWpGaD
Olanzapine—CYP2D6—Metabolism—AGT—focal segmental glomerulosclerosis	1.46e-05	8.33e-05	CbGpPWpGaD
Olanzapine—ADRA2B—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	1.45e-05	8.29e-05	CbGpPWpGaD
Olanzapine—CYP2C9—Metabolism—AGT—focal segmental glomerulosclerosis	1.45e-05	8.25e-05	CbGpPWpGaD
Olanzapine—CYP1A2—Metabolism—LPL—focal segmental glomerulosclerosis	1.45e-05	8.24e-05	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	1.44e-05	8.21e-05	CbGpPWpGaD
Olanzapine—HTR2B—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	1.43e-05	8.14e-05	CbGpPWpGaD
Olanzapine—CHRM5—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	1.41e-05	8.05e-05	CbGpPWpGaD
Olanzapine—HTR1A—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	1.4e-05	8e-05	CbGpPWpGaD
Olanzapine—HTR2C—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	1.4e-05	7.96e-05	CbGpPWpGaD
Olanzapine—ADRA2C—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	1.36e-05	7.75e-05	CbGpPWpGaD
Olanzapine—DRD1—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	1.35e-05	7.67e-05	CbGpPWpGaD
Olanzapine—ADRA1B—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	1.34e-05	7.62e-05	CbGpPWpGaD
Olanzapine—DRD3—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	1.33e-05	7.57e-05	CbGpPWpGaD
Olanzapine—CYP1A2—Metabolism—AGT—focal segmental glomerulosclerosis	1.24e-05	7.05e-05	CbGpPWpGaD
Olanzapine—DRD2—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	1.23e-05	7.03e-05	CbGpPWpGaD
Olanzapine—CYP2C19—Metabolism—ALB—focal segmental glomerulosclerosis	1.22e-05	6.95e-05	CbGpPWpGaD
Olanzapine—HTR2A—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	1.21e-05	6.92e-05	CbGpPWpGaD
Olanzapine—HRH1—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	1.21e-05	6.9e-05	CbGpPWpGaD
Olanzapine—CHRM1—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	1.21e-05	6.88e-05	CbGpPWpGaD
Olanzapine—CHRM3—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	1.2e-05	6.86e-05	CbGpPWpGaD
Olanzapine—ADRA2B—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	1.2e-05	6.83e-05	CbGpPWpGaD
Olanzapine—CHRM2—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	1.19e-05	6.79e-05	CbGpPWpGaD
Olanzapine—ABCB1—Metabolism—ALB—focal segmental glomerulosclerosis	1.19e-05	6.78e-05	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	1.19e-05	6.77e-05	CbGpPWpGaD
Olanzapine—HTR1A—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	1.16e-05	6.6e-05	CbGpPWpGaD
Olanzapine—HTR2C—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	1.15e-05	6.56e-05	CbGpPWpGaD
Olanzapine—CYP2D6—Metabolism—ALB—focal segmental glomerulosclerosis	1.12e-05	6.39e-05	CbGpPWpGaD
Olanzapine—ADRA2C—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	1.12e-05	6.38e-05	CbGpPWpGaD
Olanzapine—CYP3A4—Metabolism—LPL—focal segmental glomerulosclerosis	1.12e-05	6.36e-05	CbGpPWpGaD
Olanzapine—CYP2C9—Metabolism—ALB—focal segmental glomerulosclerosis	1.11e-05	6.33e-05	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	1.1e-05	6.29e-05	CbGpPWpGaD
Olanzapine—ADRA1B—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	1.1e-05	6.28e-05	CbGpPWpGaD
Olanzapine—DRD2—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	1.02e-05	5.79e-05	CbGpPWpGaD
Olanzapine—HTR2A—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	1e-05	5.7e-05	CbGpPWpGaD
Olanzapine—HRH1—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	9.98e-06	5.69e-05	CbGpPWpGaD
Olanzapine—CHRM1—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	9.95e-06	5.67e-05	CbGpPWpGaD
Olanzapine—CHRM3—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	9.91e-06	5.65e-05	CbGpPWpGaD
Olanzapine—CHRM2—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	9.82e-06	5.6e-05	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	9.79e-06	5.58e-05	CbGpPWpGaD
Olanzapine—CYP3A4—Metabolism—AGT—focal segmental glomerulosclerosis	9.55e-06	5.44e-05	CbGpPWpGaD
Olanzapine—CYP1A2—Metabolism—ALB—focal segmental glomerulosclerosis	9.5e-06	5.41e-05	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	9.1e-06	5.19e-05	CbGpPWpGaD
Olanzapine—CYP3A4—Metabolism—ALB—focal segmental glomerulosclerosis	7.33e-06	4.18e-05	CbGpPWpGaD
